Product Information
CLINDAMYCIN-BNZ PEROX 1-5% PMP is a generic product labeled by Glenmark Pharmaceuticals Inc., USA, priced at $0.9011 per GM under NDC 68462085927. Its NADAC has been published 248 times since Jan 5, 2022.
FDA first approved this application on Mar 14, 2019. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
50; 10 mg/g; mg/g
Manufacturer
Glenmark Pharmaceuticals Inc., USANDC
68462085927
Classification
Generic
Dosage Form
GEL
Route
TOPICAL
Effective Date
9/23/2026
Active Ingredients
BENZOYL PEROXIDE; CLINDAMYCIN PHOSPHATEApproval Type
Generic (ANDA)
FDA Application
ANDA209252FDA Approved
3/14/2019
TE Code
AB
On Market Since
9/24/2021
Pharmacological Classes
Price Statistics
The NADAC for CLINDAMYCIN-BNZ PEROX 1-5% PMP has been published 248 times since Jan 5, 2022, and over the history we have for it it has declined 34.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.9011 per GM |
|---|---|
| All-time high | $1.8087 (Feb 16, 2022) |
| All-time low | $0.4958 (Nov 20, 2024) |
| 52-week high | $1.0233 |
| 52-week low | $0.8465 |
| Median price | $1.0154 |
| Average price | $1.1574 |
| Largest weekly change | +57.3% (Jan 17, 2024) |
| Weeks tracked | 248 |
| Tracking since | Jan 5, 2022 |
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 44% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Glenmark Pharmaceuticals Inc., USA manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
clindamycin and benzoyl peroxide market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Lincosamide Antibacterial class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of CLINDAMYCIN-BNZ PEROX 1-5% PMP?
The current National Average Drug Acquisition Cost (NADAC) for CLINDAMYCIN-BNZ PEROX 1-5% PMP, manufactured by Glenmark Pharmaceuticals Inc., USA, is $0.9011 per GM (NDC 68462085927), effective Sep 30, 2026.
How has the price of CLINDAMYCIN-BNZ PEROX 1-5% PMP changed over time?
Over the history we have for it, the NADAC for CLINDAMYCIN-BNZ PEROX 1-5% PMP has declined 34.8%. It has been tracked across 248 weekly CMS publications since Jan 5, 2022.
What are the highest and lowest recorded NADAC prices for CLINDAMYCIN-BNZ PEROX 1-5% PMP?
Since Jan 5, 2022, the NADAC for CLINDAMYCIN-BNZ PEROX 1-5% PMP has ranged from a low of $0.4958 (Nov 20, 2024) to a high of $1.8087 (Feb 16, 2022), with a median of $1.0154 per GM.
Are there cheaper alternatives to CLINDAMYCIN-BNZ PEROX 1-5% PMP?
Yes. 2 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, CLINDAMYCIN-BENZOYL PEROX 1-5%, is $0.5007 per GM — about 44% below CLINDAMYCIN-BNZ PEROX 1-5% PMP.
Who manufactures CLINDAMYCIN-BNZ PEROX 1-5% PMP?
CLINDAMYCIN-BNZ PEROX 1-5% PMP (NDC 68462085927) is labeled by Glenmark Pharmaceuticals Inc., USA, and CMS classifies it as a generic product.